We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Device Treats Cervical Degenerative Disc Disease

By HospiMedica staff writers
Posted on 06 Aug 2007
An artificial cervical disc has been developed for the treatment of cervical degenerative disc disease, one of the most common causes of neck and arm pain.

The Prestige Cervical Disc consists of two main pieces of stainless steel that articulate against one another with a ball and trough articulation, in order to allow physiologic translation of the motion segment. More...
After removal of the impaired natural disc, the artificial disc is attached to the adjacent vertebrae with bone screws.

The artificial cervical disc has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of cervical degenerative disc disease. The approval was based on laboratory and animal testing, and on a clinical study of 541 patients. The clinical study showed that the device improved neck and/or arm pain, and was as safe and effective as cervical fusion, the standard treatment for degenerative disc disease. As a condition of approval, the company will conduct a study over the next seven years to evaluate the longer-term safety and effectiveness of the device. The Prestige Cervical Disc is made by Medtronic Sofamor Danek (Memphis, TN, USA).

"The approval of this artificial disc means that people with cervical degenerative disc disease now will have another surgical option for treating this condition,” said Daniel Schultz, M.D., director of the center for devices and radiological health at the FDA. "This device will help relieve pain and restore function.”

Current surgical treatment involves removing a diseased or bulging disc in a patient's neck and fusing two or more bony vertebrae.


Related Links:
Medtronic Sofamor Danek

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.